Nationwide Genomic Surveillance of Human Respiratory Adenoviruses in 2023–2024: Evidence of Extensive Diversity and Recombination in Russia
Viruses · 2026
DOI: 10.3390/v18010136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Nikita D Yolshin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Genome, Viral, Recombination, Genetic, Genetic Variation, Adenoviruses, Human. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health of the Russian Federation.
Abstract (Originalsprache)
Human adenoviruses (HAdVs) are globally distributed pathogens capable of causing a wide range of clinical manifestations, particularly acute respiratory infections. However, their genomic diversity remains insufficiently characterized, with substantial geographic gaps in available sequence data, including for Russia, where only a few complete genomes have been deposited prior to this work. In this study, we analyzed more than 1200 PCR-positive respiratory specimens collected from hospitalized patients within routine surveillance projects and the Global Influenza Hospital Surveillance Network (GIHSN) across plenty of Russian regions during 2023–2024. Virus isolation followed by next-generation sequencing yielded 128 complete HAdV genomes representing species B, C, and D. The dataset included 27 B3, 9 B7, 44 B55, 12 C1, 16 C2, 4 C5, 7 C89, 5 C108, and one D109 genome, as well as three unassigned recombinant viruses with p89h5f5, p5h6f6 and p5h57f6 genomic structures (p, penton base; h, hexon; f, fiber). Phylogenetic analyses of whole genomes and capsid genes revealed extensive variability in immunogenic regions, particularly in species C, and identified clusters within B3 viruses. Notably, HAdV-D109 was identified in Russia, marking only the second reported detection of this genotype worldwide. Together, these findings substantially expand the currently available genomic landscape of HAdVs, highlighting the circulation of diverse and recombinant strains in Russia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Smorodintsev Research Institute of Influenza, 197376 Saint Petersburg, Russia.
- Department of Infectious Diseases and Epidemiology, Pavlov First Saint Petersburg State Medical University, 197022 Saint Petersburg, Russia.
ORCID-Profile: Nikita D Yolshin, Alexander A Perederiy, Dmitry A Lioznov, Andrey B Komissarov
Förderung
- Ministry of Health of the Russian Federation
Zitieren
APA
Yolshin, N. D., Ivanova, A. A., Perederiy, A. A., Amosova, I. V., Timoshicheva, T. A., Stolyarov, K. A., Danilenko, D. M., Lioznov, D. A., & Komissarov, A. B. (2026). Nationwide Genomic Surveillance of Human Respiratory Adenoviruses in 2023–2024: Evidence of Extensive Diversity and Recombination in Russia. Viruses. https://doi.org/10.3390/v18010136
Vancouver
Yolshin ND, Ivanova AA, Perederiy AA, Amosova IV, Timoshicheva TA, Stolyarov KA, et al. Nationwide Genomic Surveillance of Human Respiratory Adenoviruses in 2023–2024: Evidence of Extensive Diversity and Recombination in Russia. Viruses. 2026. doi:10.3390/v18010136
BibTeX
@article{Yolshin2026,
author = {Yolshin, Nikita D and Ivanova, Anna A and Perederiy, Alexander A and Amosova, Irina V and Timoshicheva, Tatyana A and Stolyarov, Kirill A and Danilenko, Daria M and Lioznov, Dmitry A and Komissarov, Andrey B},
title = {Nationwide Genomic Surveillance of Human Respiratory Adenoviruses in 2023–2024: Evidence of Extensive Diversity and Recombination in Russia},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18010136}
}
EUVIMED